Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sunwin Stevia International Inc. (SUWN : OTC)

• Company Description    Sunwin Stevia International, Inc. is an agricultural processing firm engaged in the manufacture and sale of a wide range of neutraceutical products. Its product lines include zero-calorie all natural Stevia sweeteners and traditional Chinese medicines. The Company provides OnlySweet (TM), a stevioside-based table top sweetener to health food retailers, national and regional grocery chains in the U.S. Sunwin Stevia International, Inc., formerly known as Sunwin International Neutraceuticals, Inc., is headquartered in Qufu, China. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $0.00 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6 SHENGWANG AVENUE - QUFU SHANDONG,F4 273100 CHN ph: 86-53-7442-4999 fax: 86-53-7441-3350 ir@sunwininternational.com http://www.sunwininternational.com

• General Corporate Information    Officers Chunchun Wang - Chief Executive Officer; Secretary and Director Fanjun Wu - Chief Financial Officer Yuyi Liu - Director Yuqiang Lai - Director - - - Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-GENERIC DRG Sector: Medical CUSIP: 86803D109 SIC: 2834 Fiscal Year Fiscal Year End: April Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 07/31/25 - - 04/30/25 - - 01/31/25 - - ROA 07/31/25 - - 04/30/25 - - 01/31/25 - - Current Ratio 07/31/25 - - 04/30/25 - - 01/31/25 - - Quick Ratio 07/31/25 - - 04/30/25 - - 01/31/25 - - Operating Margin 07/31/25 - - 04/30/25 - - 01/31/25 - - Net Margin 07/31/25 - - 04/30/25 - - 01/31/25 - - Pre-Tax Margin 07/31/25 - - 04/30/25 - - 01/31/25 - - Book Value 07/31/25 - - 04/30/25 - - 01/31/25 - - Inventory Turnover 07/31/25 - - 04/30/25 - - 01/31/25 - - Debt-to-Equity 07/31/25 - - 04/30/25 - - 01/31/25 - - Debt-to-Capital 07/31/25 - - 04/30/25 - - 01/31/25 - -

Powered by Zacks Investment Research ©